HARRY KELLY
MAMMOTH SPRINGS, AR NPI 1285705848
Browse related groups: AR Novo Nordisk AS All categories
General Payments — all program years on this page
$204.15
- Category: General Payments
- Program years: PY2018–2019
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $84.78 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $84.78 | 7 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $35.33 | 3 |
| Acerta Pharma LLC | $33.86 | 3 |
| Amgen Inc. | $15.59 | 1 |
By program year
Records — PY2019 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 662382066 | Amgen Inc. | $15.59 | 03/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 668762173 | Novo Nordisk Inc | $12.10 | 02/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669556941 | Novo Nordisk Inc | $11.79 | 04/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669556943 | Novo Nordisk Inc | $11.44 | 04/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 685045103 | AstraZeneca Pharmaceuticals LP | $11.07 | 03/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 685117477 | AstraZeneca Pharmaceuticals LP | $11.54 | 02/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 685227229 | AstraZeneca Pharmaceuticals LP | $11.25 | 03/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.